Skip to main content
Article thumbnail
Location of Repository

The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population

By Uk Hyun Jo, Sle Gi Lo Han, Jae Hong Seo, Kyong Hwa Park, Jae Won Lee, Hyo Jung Lee, Jeong Seon Ryu and Yeul Hong Kim
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2004). A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell
  2. (2006). Association of the PDCD5 locus with lung cancer risk and prognosis in smokers.
  3. (2000). CC: Cancer risk and low-penetrance susceptibility genes in gene-environment interactions.
  4. (2004). Chanock SJ: SNPs in cancer research and treatment.
  5. (2001). Devesa SS: Cancer burden in the year 2000. The global picture.
  6. (2007). EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet Cytogenet
  7. (2006). Hong YC: Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. Hum Mol Genet
  8. (2002). Hopkin JM: Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer
  9. (2002). Lung Cancer in Korea. Cancer Res Treat
  10. (1986). T: The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science
  11. (1986). The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.